Automated identification of circulating tumor cells by image cytometry

Cytometry Part A

Volumn 81 A, Issue 2, 2012, Pages 138-148

  Scholtens, Tycho M ^a   Schreuder, Frederik ^a   Ligthart, Sjoerd T ^a   Swennenhuis, Joost F ^a   Greve, Jan ^a   Terstappen, Leon W M M ^a  

^a UNIVERSITY OF TWENTE   (Netherlands)

Author keywords

Automated classification; Cell analysis; CTC; Image cytometry; Random Forest; TDI

Indexed keywords

APOPTOSIS; ARTICLE; AUTOMATION; CELL COUNT; CELL TRACKING; CLASSIFICATION; HUMAN; IMAGE CYTOMETRY; INSTRUMENTATION; LEUKOCYTE; METASTASIS; METHODOLOGY; OBSERVER VARIATION; PATHOLOGY; STATISTICS; TUMOR EMBOLISM;

APOPTOSIS; AUTOMATION; CELL COUNT; CELL TRACKING; HUMANS; IMAGE CYTOMETRY; LEUKOCYTES; NEOPLASM METASTASIS; NEOPLASTIC CELLS, CIRCULATING; OBSERVER VARIATION; STATISTICS AS TOPIC;

EID: 84856234581     PISSN: 15524922     EISSN: 15524930     Source Type: Journal    
DOI: 10.1002/cyto.a.22002     Document Type: Article

References (60)

1. Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, Rueben JMDoyle G, Allard WJ, Terstappen LWMM, et al. Circulating tumor cells, disease progression and survival in metastatic breast cancer.NEJM 2004;351:781-791.
2. Liu MC, Shields PG, Warren RW, Cohen P, Wilkinson M, Ottaviano YL, Rao SB, Eng-Wong J, Seillier-Moiseiwitsch F, Noone AM, et al. Circulating tumor cells: A useful predictor of treatment efficacy in metastatic breast cancer.JCO 2009;27:5153-5159.
3. Cohen SJ, Punt CJA, Iannotti N, Saidman BH, Sabbath KD, Gabrail NY, Picus J, Morse M, Mitchell E, Miller MC, et al. The relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer.JCO 2008;26:3213-3221.
4. Tol J, Koopman M, Miller MC, Tibbe A, Cats A, Creemers GJM, Vos AH, Nagtegaal ID, Terstappen LWMM, Punt CJA.Circulating tumour cells early predict progression-free and overall survival in advanced colorectal cancer patients treated with chemotherapy and targeted agents.Ann Oncol 2010;21:1006-1012.
5. DeBono JS, Scher HI, Montgomery RB, Parker C, Miller MC, Tissing H, Doyle GV, Terstappen LWMM, Pienta KJ, Raghavan D.Circulating tumor cells (CTC) predict survival benefit from treatment in metastatic castration resistant prostate cancer (CRPC).Clin Can Res 2008;14:6302-6309.
6. Olmos D, Arkenau HT, Ang JE, Ledaki I, Attard G, Carden CP, Reid AHM, Hem RA, Fong PC, Oomen NB, et al. Circulating Tumor Cells (CTC) as intermediate end points in castration-resistant prostate cancer (CRPC): A single-centre experience.Ann Oncol 2009;20:27-37.
7. Nagrath S, Sequist LV, Maheswaran S, Bell DW, Irimia D, Ulkus L, Smith MR, Kwak EL, Digumarthy S, Muzikansky A, et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology.Nature 2007;450:1235-1241.
8. Pachmann K, Camara O, Kavallaris A, Krauspe S, Malarski N, Gajda M, Kroll T, Jörke C, Hammer U, Altendorf-Hofmann A, et al. Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse.JCO 2008;26:1208-1215.
9. Kahn HJ, Presta A, Yang LY, Blondal J, Trudeau M, Lickley L, Holloway C, McCready DR, Maclean D, Marks A.Enumeration of circulating tumor cells in the blood of breast cancer patients after filtration enrichment: Correlation with disease stage.Breast Cancer Res Treat 2004;86:237-247.
10. Krivacic RT, Ladanyi A, Curry DN, Hsieh HB, Kuhn P, Bergsrud DE, Kepros JF, Barbera T, Ho MY, Chen LB, et al. A rare-cell detector for cancer.Proc Natl Acad Sci USA 2004;101:10501-10504.
11. Hsieh HB, Marrinucci D, Bethel K, Curry DN, Humphrey M, Krivacic RT, Kroener J, Kroener L, Ladanyi A, Lazarus N, et al. High speed detection of circulating tumor cells.Biosens Bioelectron 2006;21:1893-1899.
12. Racila E, Euhus D, Weiss AJ, Rao C, McConnell J, Terstappen LWMM, Uhr JW.Detection and characterization of carcinoma cells in the blood.Proc Natl Acad Sci USA 1998;95:4589-4594.
13. Coumans F, Doggen CJM, Attard G, de Bono JS, Terstappen LWMM.All circulating EpCAM+CD45-CK+ but not EpCAM+CD45+CK+ objects predict overall survival in castration-resistant prostate cancer.Ann Oncol 2010;21:1851-1857.
14. Allard WJ, Matera J, Miller MC, Repollet M, Connelly MC, Rao C, Tibbe A, Uhr JW, Terstappen LWMM.Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with non-malignant diseases.Clin Can Res 2004;10:6897-6904.
15. Kagan M, Howard D, Bendele T, Mayes J, Silvia J, Repollet M, Doyle J, Allard J, Tu N, Bui T, et al. A sample preparation and analysis system for identification of circulating tumor cells.J Clinical Ligand Assay 2002;25:104-110.
16. Tibbe AGJ, Miller C, Terstappen LWMM.Statistical considerations for enumeration of circulating tumor cells.Cytometry Part A 2007;71A:154-162.
17. Larson CJ, Moreno JG, Pienta KJ, Gross S, Repollet M, O'Hara SM, Russell T, Terstappen LWMM.Apoptosis of circulating tumor cells in prostate cancer patients.Cytometry Part A 2004;62A:46-53.
18. Scholtens TM, Schreuder F, Ligthart ST, Swennenhuis JF, Tibbe AGJ, Greve J, Terstappen LWMM.CellTracks TDI: An image cytometer for cell characterization.Cytometry Part A 2011;79A:203-213.
19. Schreuder F. Laser Image Cytometer for Analysis of Circulating Tumor Cells. ISBN 978-90-365-2610-4, January 2008 (Thesis).
20. Tibbe AGJ, de Grooth BG, Greve J, Dolan GJ, Rao C, Terstappen LWMM.Magnetic field design for selecting and aligning immunomagnetic labeled cells.Cytometry 2002;47:163-172.
21. Ortyn WE, Hall BE, George TC, Frost K, Basiji DA, Perry DJ, Zimmerman CA, Coder D, Philip J, Morrissey PJ.Sensitivity measurement and compensation in spectral imaging.Cytometry Part A 2006;69A:852-862.
22. Rasband WS.ImageJ.Maryland, USA:US National Institutes of Health, Bethesda.
23. Abramoff MD, Magelhaes PJ, Ram SJ.Image processing with ImageJ.Biophoton Int 2004;11:36-42.
24. Liao PS, Chen TS, Chung PC.A fast algorithm for multilevel thresholding.J Info Sci Eng 2001;17:713-727.
25. Breiman L.Bagging predictors.Mach Learn 1996;24:123-140.
26. Breiman L.Random forests.Mach Learn 2001;45:5-32.
27. Wu B, Abbott T, Fishman D, McMurray W, Mor G, Stone K, Ward D, Williams K, Zhao H.Comparison of statistical methods for classification of ovarian cancer using mass spectrometry data.Bioinformatics 2003;19:1636-1643.
28. Gislason PO, Benediktsson JA, Sveinsson JR.Random forests for land cover classification.Pattern Recog Lett 2006;27:294-300.
29. Ho TK.The random subspace method for constructing decision forests.IEEE Trans Pattern Anal Mach Intell 1998;20:832-844.
30. Ham J, Chen Y, Crawford MM, Ghosh J.Investigation of the random forest framework for classification of hyperspectral data.IEEE Trans Geosci Remote Sens 2005;43:492-501.
31. Geng W, Cosman P, Berry CC, Feng Z, Schafer WR.Automatic tracking, feature extraction and classification of C. elegans phenotypes.IEEE Trans Biomed Eng 2004;51:1811-1820.
32. Ramírez J, Górriz JM, Chaves R, López M, Salas-Gonzalez D, Álvarez I, Segovia F.SPECT image classification using random forests.Electron Lett 2009;45:604-605.
33. Kovalev V, Harder N, Neumann B, Held M, Liebel U, Erfle H, Ellenberg J, Eils R, Rohr K.Feature selection for evaluating fluorescence microscopy images in genome-wide cell screens.Proceedings of the IEEE Computer Society Conference on Computer Vision and Pattern Recognition 2006;1:276-283.
34. Newberg JY, Li J, Rao A, Ponten F, Uhlen M, Lundberg E, Murphy RF.Automated analysis of human protein atlas immunofluorescence images.Proceedings of the IEEE Int Symp Biomed Imag 2009;1023-1026.
35. Khoshgoftaar TM, Golawala M, Van Hulse J. An empirical study of learning from imbalanced data using random forest. 19th IEEE International Conference on Tools with Artificial Intelligence 2007;2:310-317.
36. Landis JR, Koch GG.The measurement of observer agreement for categorical data.Biometrics 1977;33:159-74.
37. Cohen J.Weighted kappa: Nominal scale agreement provision for scaled disagreement or partial credit.Psychol Bull 1968;70:213-220.
38. Sim J, Wright CC.The Kappa statistic in reliability studies: Use, interpretation, and sample size requirements.Phys Ther 2005;85:257-268.
39. Fleiss JL.Measuring nominal scale agreement among many raters.Psychol Bull 1971;76:378-382.
40. Attard G, Swennenhuis JF, Olmos D, Reid AHM, Vickers E, A'Hern R, Levink R, Coumans F, Moreira J, Riisnaes R, et al. Characterization of ERG, AR and PTEN status in circulating tumor cells from patients with castration-resistant prostate cancer.Cancer Res 2009;69:2912-2918.
41. Swennenhuis JF, Tibbe AGJ, Levink R, Sipkema RCJ, Terstappen LWMM.Characterization of circulating tumor cells by fluorescence in-situ hybridization.Cytometry Part A 2009;75A:520-527.
42. Rao CG, Chianese D, Doyle GV, Miller MC, Russell T, Sanders RA, Terstappen LWMM.Expression of epithelial cell adhesion molecule in carcinoma cells present in blood and primary and metastatic tumors.Int J Oncol 2005;27:49-58.
43. Leers MPG, Björklund V, Björklund B, Jörnvall H, Nap M.An immunohistochemical study of the clearance of apoptotic cellular fragments.Cell Mol Life Sci 2002;59:1358-1365.
44. Ku N, Liao J, Omary MB.Apoptosis generates stable fragments of human type I keratins.J Bio Chem 1997;272:33197-33203.
45. Wang ZP, Eisengberger M, Carducci M, Partin A, Scher H, Ts'o POP.Identification and characterization of circulating prostate carcinoma cells.Cancer 2000;88:2787-2795.
46. Mehes G, Witt A, Kubista E, Ambros P.Circulating breast cancer cells are frequently apoptotic.Am J Pathol 2001;159:17-20.
47. Hägg M, Biven K, Ueno T, Rydlander L, Björklund P, Wiman KG, Shoshan M, Linder S.A novel high-through-put assay for screening of pro-apoptotic drugs.Invest New Drugs 2002;20:253-259.
48. Schutte B, Henfling M, Kolgen W, Bouman M, Meex S, Leers MPG, Nap M, Björklund V, Björklund P, Björklund B, et al. Keratin 8/18 breakdown and reorganization during apoptosis.Exp Cell Res 2004;297:11-26.
49. Kramer G, Erdal H, Mertens HJMM, Nap M, Mauermann J, Steiner G, Marberger M, Biven K, Shoshan MC, Linder S.Differentiation between cell death modes using measurements of different soluble forms of extracellular cytokeratin 18.Cancer Res 2004;64:1751-1756.
50. Jahr S, Hentze H, Englisch S, Hardt D, Fackelmayer FO, Hesch R, Knippers R.DNA fragments in the blood plasma of cancer patients: Quantitations and evidence for their origin from apoptotic and necrotic cells.Cancer Res 2001;61:1659-1665.
51. Olofsson MH, Ueno T, Pan Y, Xu R, Cai F, van der Kuip H, Muerdter TE, Sonnenberg M, Aulitzky WE, Schwarz S, et al. Cytokeratin-18 is a useful serum biomarker for early determination of response of breast carcinomas to chemotherapy.Clin Cancer Res 2007;11:3198-3206.
52. Lai RS, Hsu HK, Lu JY, Ger LP, Lai NS.CYFRA 21-1 enzyme-linked immunosorbent assay evaluation as a tumor marker in non-small cell lung cancer. Chest 1996;109:995-1000.
53. Alix-Panabieres C, Brouillet JP, Fabbro M, Yssel H, Rousset T, Maudelonde T, Choquet-Kastylevsky G, Vendrell JP.Characterization and enumeration of cells secreting tumor markers in the peripheral blood of breast cancer patients.J Immunol Methods 2005;299:177-188.
54. Kahn HJ, Presta A, Yang LY, Blondal J, Trudeau M, Lickley L, Holloway C, McCready DR, Maclean D, Marks A.Enumeration of circulating tumor cells in the blood of breast cancer patients after filtration enrichment: Correlation with disease stage.Breast Cancer Res Treat 2004;86:237-247.
55. Krivacic RT, Ladanyi A, Curry DN, Hsieh HB, Kuhn P, Bergsrud DE, Kepros JF, Barbera T, Ho MY, Chen LB, et al. A rare-cell detector for cancer.Proc Natl Acad Sci USA 2004;101:10501-10504.
56. Vona G, Sabile A, Louha M, Sitruk V, Romana S, Schutze K, Capron F, Franco D, Pazzagli M, Vekemans M, et al. Isolation by size of epithelial tumor cells: A new method for the immunomorphological and molecular characterization of circulating tumor cells.Am J Pathol 2000;156:57-63.
57. Gleghorn JP, Pratt ED, Denning D, Liu H, Bander NH, Tagawa ST, Nanus DM, Giannakakou PA, Kirby BJ.Capture of circulating tumor cells from whole blood of prostate cancer patients using geometrically enhanced differential immunocapture (GEDI) and a prostate-specific antibody.Lab on a Chip - Miniaturisation for Chemistry and Biology 2010;10:27-29.
58. Königsberg R, Obermayr E, Bises G, Pfeiler G, Gneist M, Wrba F, De Santis M, Zeillinger R, Hudec M, Dittrich C.Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients.Acta Oncol 2011;50:700-710.
59. Gascoyne PRC, Noshari J, Anderson TJ, Becker FF.Isolation of rare cells from cell mixtures by dielectrophoresis.Electrophoresis 2009;30:1388-1398.
60. Tan SJ, Lakshmi RL, Chen P, Lim WT, Yobas L, Lim CT.Versatile label free biochip for the detection of circulating tumor cells from peripheral blood in cancer patients.Biosensors and Bioelectronics 2010;26:1701-1705.